Phase 3

As Psilocybin Trials Face Delays, Compass Pathways (CMPS) Cuts Workforce To Conserve Cash

Novo Nordisk's Once-Weekly Insulin Icodec Shows Favorable Reduction In HbA1c In Type 2 Diabetes

InflaRx Secures €44M Grant From German Govt To Advance Its COVID-19 Trial

Novo Nordisk's Once-Weekly Insulin Icodec Shows Favorable Reduction In HbA1c In Type 2 Diabetes

InflaRx Secures €44M Grant From German Govt To Advance Its COVID-19 Trial

AbbVie Presents New Upadacitinib Data In Atopic Dermatitis

Pfizer-BioNTech COVID-19 Shot Safe, Effective Through Six Months After Second Dose

AbbVie Presents New Upadacitinib Data In Atopic Dermatitis

Pfizer-BioNTech COVID-19 Shot Safe, Effective Through Six Months After Second Dose

Chiasma's Mycapssa Improves Acromegaly Related Symptoms After Switching From iSRLs

Strongbridge Biopharma Stock Trading Higher On Detailed Recorlev Data In Cushing's Syndrome

Phase 3 Recent News

Ocuphire Pharma Stock Is Trading Higher After Nyxol Aces Late-Stage Study

Ocuphire Pharma Inc (NASDAQ: OCUP) stock is soaring in the premarket in reaction to

PhaseBio Recruits BioVectra As Manufacturing Partner For Bentracimab

PhaseBio Pharmaceuticals Inc (NASDAQ: PHAS)

Roche's Tocilizumab, Gilead's Remdesivir Combo Fails To Improve Hospital Discharge Time in COVID-19 Study

Roche Holdings AG (OTCQX: RHHBY) has

Vir/GSK's COVID-19 Antibody Therapy Cuts Hospitalization, Deaths by 85%, Seeks FDA Emergency Use Nod

An Independent Data Monitoring Committee (IDMC) has recommended that the Phase 3 COMET-ICE trial, evaluating VIR-7831 (GSK4182136) as monotherapy for COVID-19,

Eli Lilly's Tirzepatide Tops Novo's Semaglutide In Late-Stage Diabetes Study

Eli Lilly & Co (NYSE: LLY) has reported

Vascular Biogenics' Ovarian Cancer Gene Therapy Shows Response Rate Of Over 58%

BioXcel's BXCL501 Lower Dose Shows Statistical Significance On Agitation Scales

BioXcel Therapeutics Inc (NASDAQ: BTAI)

Eli Lilly/Incyte's Baricitinib Shows Benefit In Patchy Hair Loss Disorder

Eli Lilly and Co (NYSE: LLY) and Incyte Corporation (NASDAQ:

United Therapeutics Pulls Plug On Trevyent Development

Based on the FDA’s written comments, United Therapeutics Corporation (NASDAQ: UTHR) has

Ocugen Shares Are Trading Higher On Its Partner's COVID-19 Vaccine Candidate Showing 81% Efficacy

Ocugen Inc (NASDAQ: OCGN) shares soared in the premarket on heavy volume after Bharat Biotech, the company's COVID-19 vaccine development partner in India,

Novavax Bullish On Potential FDA EUA Nod For COVID-19 Vaccine By May

Novavax Inc’s (NASDAQ: NVAX) COVID-19 shot can probably win FDA emergency use nod as early as May, said the company’s CEO Stanley Erck,

Glaukos' iLink Therapy Meets Primary Endpoint In Late-Stage Vision Disorder Study

Karyopharm's Partner Antengene Receives Priority Review For Selinexor Application In China

RedHill Biopharma, Cosmo Pharma In Manufacturing Pact for Movantik, RHB-204

Seagen/Astellas Pharma Seek Approval For PADCEV's Expanded Use In Urothelial Cancer Settings

Galapagos, Gilead Sciences Pull Plug On Ziritaxestat Clinical Trials

Opdivo Plus Cabometyx Combo Shows Superior Clinical Benefit Versus Sunitinib In Late-Stage Kidney Cancer Study

Janssen's Erleada Plus, Zytiga Plus Prednisone Combo Treatment Shows Clinical Benefit In Late-Stage Prostate Cancer Study

Veru's COVID-19 Drug Candidate Shows High Relative Reduction In Treatment Failures, Mortality In Mid-Stage Study

Calliditas Starts Dosing In Nefecon Open Label Extension Study In Kidney Disease

Otonomy Rips 90% After Meniere's Disease Drug Achieves Primary Endpoint

Rigorous Trial Design, Nice Risk/Reward Keep Analyst Anxious For Avoxant's Phase 3 MINDSET Data

Galena Shares Up 50% On Regulatory Pathway For Thrombosis Treatment